Human CAMK2B/CAM2/CAMK2 ORF/cDNA clone-Lentivirus particle (NM_172081)
Cat. No.: vGMLP003363
Pre-made Human CAMK2B/CAM2/CAMK2 Lentiviral expression plasmid for CAMK2B lentivirus packaging, CAMK2B lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
CaMKII/CAMK2B/CAMK2B/CAM2 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
| Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
|---|---|---|---|
| vGMLP003363 | Human CAMK2B Lentivirus particle | Pilot Grade | 1.0E+8TU |
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| Research Grade | 1.0E+8TU | ||
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMLP003363 |
| Gene Name | CAMK2B |
| Accession Number | NM_172081 |
| Gene ID | 816 |
| Species | Human |
| Product Type | Lentivirus particle (overexpression) |
| Insert Length | 1512 bp |
| Gene Alias | CAM2,CAMK2,CAMKB,MRD54 |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGCCACCACGGTGACCTGCACCCGCTTCACCGACGAGTACCAGCTCTACGAGGATATTGGCAAGGGGGCTTTCTCTGTGGTCCGACGCTGTGTCAAGCTCTGCACCGGCCATGAGTATGCAGCCAAGATCATCAACACCAAGAAGCTGTCAGCCAGAGATCACCAGAAGCTGGAGAGAGAGGCTCGGATCTGCCGCCTTCTGAAGCATTCCAACATCGTGCGTCTCCACGACAGCATCTCCGAGGAGGGCTTCCACTACCTGGTCTTCGATCTGGTCACTGGTGGGGAGCTCTTTGAAGACATTGTGGCGAGAGAGTACTACAGCGAGGCTGATGCCAGTCACTGTATCCAGCAGATCCTGGAGGCCGTTCTCCATTGTCACCAAATGGGGGTCGTCCACAGAGACCTCAAGCCGGAGAACCTGCTTCTGGCCAGCAAGTGCAAAGGGGCTGCAGTGAAGCTGGCAGACTTCGGCCTAGCTATCGAGGTGCAGGGGGACCAGCAGGCATGGTTTGGTTTCGCTGGCACACCAGGCTACCTGTCCCCTGAGGTCCTTCGCAAAGAGGCGTATGGCAAGCCTGTGGACATCTGGGCATGTGGGGTGATCCTGTACATCCTGCTCGTGGGCTACCCACCCTTCTGGGACGAGGACCAGCACAAGCTGTACCAGCAGATCAAGGCTGGTGCCTATGACTTCCCGTCCCCTGAGTGGGACACCGTCACTCCTGAAGCCAAAAACCTCATCAACCAGATGCTGACCATCAACCCTGCCAAGCGCATCACAGCCCATGAGGCCCTGAAGCACCCGTGGGTCTGCCAACGCTCCACGGTAGCATCCATGATGCACAGACAGGAGACTGTGGAGTGTCTGAAAAAGTTCAATGCCAGGAGAAAGCTCAAGGGAGCCATCCTCACCACCATGCTGGCCACACGGAATTTCTCAGCAGCCAAGAGTTTACTCAACAAGAAAGCAGATGGAGTCAAGCCCCAGACGAATAGCACCAAAAACAGTGCAGCCGCCACCAGCCCCAAAGGGACGCTTCCTCCTGCCGCCCTGGAGTCTTCTGACAGTGCCAATACCACCATAGAGGATGAAGACGCTAAAGCCCGGAAGCAGGAGATCATTAAGACCACGGAGCAGCTCATCGAGGCCGTCAACAACGGTGACTTTGAGGCCTACGCGAAAATCTGTGACCCAGGGCTGACCTCGTTTGAGCCTGAAGCACTGGGCAACCTGGTTGAAGGGATGGACTTCCACAGATTCTACTTCGAGAACCTGCTGGCCAAGAACAGCAAGCCGATCCACACGACCATCCTGAACCCACACGTGCACGTCATTGGAGAGGATGCCGCCTGCATCGCTTACATCCGGCTCACGCAGTACATTGACGGGCAGGGCCGGCCCCGCACCAGCCAGTCTGAGGAGACCCGCGTGTGGCACCGCCGCGACGGCAAGTGGCAGAACGTGCACTTCCACTGCTCGGGCGCGCCTGTGGCCCCGCTGCAGTGA |
| ORF Protein Sequence | MATTVTCTRFTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITAHEALKHPWVCQRSTVASMMHRQETVECLKKFNARRKLKGAILTTMLATRNFSAAKSLLNKKADGVKPQTNSTKNSAAATSPKGTLPPAALESSDSANTTIEDEDAKARKQEIIKTTEQLIEAVNNGDFEAYAKICDPGLTSFEPEALGNLVEGMDFHRFYFENLLAKNSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWQNVHFHCSGAPVAPLQ |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-IP0246-Ab | Anti-CAMK2B monoclonal antibody |
| Target Antigen | GM-Tg-g-IP0246-Ag | CAMK2B protein |
| ORF Viral Vector | pGMLP003363 | Human CAMK2B Lentivirus plasmid |
| ORF Viral Vector | pGMLP005180 | Human CAMK2B Lentivirus plasmid |
| ORF Viral Vector | vGMLP003363 | Human CAMK2B Lentivirus particle |
| ORF Viral Vector | vGMLP005180 | Human CAMK2B Lentivirus particle |
Target information
| Target ID | GM-IP0246 |
| Target Name | CaMKII/CAMK2B |
|
Gene Group Identifier (Target Gene ID in Homo species) |
816 |
| Gene ID |
100146368 (Equus caballus), 101098615 (Felis catus), 12323 (Mus musculus), 24245 (Rattus norvegicus) 482687 (Canis lupus familiaris), 525416 (Bos taurus), 706977 (Macaca mulatta), 816 (Homo sapiens) |
| Gene Symbols & Synonyms | CAMK2B,Camk2b,CaMKII,Ck2b,CAM2,CAMK2,CAMKB,MRD54,CaMKIIbeta |
| Target Alternative Names | CAM2,CAMK2,CAMK2B,CAMKB,CaM kinase II subunit beta,CaMK-II subunit beta,CaMKII,CaMKIIbeta,Calcium/calmodulin-dependent protein kinase type II subunit beta,Camk2b,Ck2b,MRD54 |
| Uniprot Accession |
P08413,P28652,Q13554,Q3MHJ9
Additional SwissProt Accessions: P28652,P08413,Q3MHJ9,Q13554 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | Therapeutics Target |
| Disease | |
| Disease from KEGG | ErbB signaling pathway, Calcium signaling pathway, cAMP signaling pathway, HIF-1 signaling pathway, Adrenergic signaling in cardiomyocytes, Wnt signaling pathway, Axon guidance, Circadian entrainment, Long-term potentiation, Neurotrophin signaling pathway, Cholinergic synapse, Olfactory transduction, Inflammatory mediator regulation of TRP channels, Insulin secretion, GnRH signaling pathway, Melanogenesis, Oxytocin signaling pathway, Aldosterone synthesis and secretion, Cushing syndrome, Gastric acid secretion, Amphetamine addiction, Tuberculosis, Pathways in cancer, Proteoglycans in cancer, Glioma, Lipid and atherosclerosis |
| Gene Ensembl | ENSECAG00000017000, ENSMUSG00000057897, ENSCAFG00845012770, ENSBTAG00000012653, ENSMMUG00000002433, ENSG00000058404 |
| Target Classification | Kinase |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


